Knowledge Insight: Evaluating IgA Nephropathy Progression and Treatment Response Using IgA Surpass ELISA Kits
Knowledge Insight: Evaluating IgA Nephropathy Progression and Treatment Response Using IgA Surpass ELISA Kits
Brought to you by ANT BIO PTE. LTD.
1. Core Concepts
IgA nephropathy is the most prevalent primary glomerulonephritis worldwide. Its pathological hallmark is the abnormal deposition of galactose-deficient IgA1 (Gd-IgA1) and immune complexes in the glomerular mesangium, leading to inflammation, hematuria, proteinuria, and progressive renal injury.
Renal biopsy remains the diagnostic gold standard but is invasive. Non-invasive biomarkers such as IgA and Gd-IgA1 enable safer monitoring of disease activity, prognosis, and therapeutic efficacy.
2. Research Frontiers
Recent advances in IgA nephropathy research focus on:
- Non-invasive detection of Gd-IgA1 and immune complexes
- Prognostic stratification using serum IgA subclass profiles
- Therapeutic monitoring via dynamic IgA biomarker changes
- High-sensitivity ELISA systems for preclinical model research
- Development of targeted immunosuppressive therapies
3. Research Significance
Accurate IgA quantification supports:
- Non-invasive auxiliary diagnosis of IgA nephropathy
- Assessment of disease activity and renal prognosis
- Evaluation of treatment response to RASI or immunosuppressants
- Early warning of disease relapse
- Preclinical research in mouse models of renal disease
Reliable IgA ELISA tools are essential for translational and clinical research.
4. Clinical Value & Technical Principles
Key Prognostic Factors in IgA Nephropathy
- Sustained proteinuria >1 g/day
- Poor blood pressure control
- Decline in renal function
- Elevated Gd-IgA1 levels
Stepwise Clinical Management
- Low-risk patients: lifestyle management and observation
- Moderate-risk: renin-angiotensin system inhibition
- High-risk: immunosuppressive therapy
Role of IgA Surpass ELISA Kits
- Quantify total IgA and Gd-IgA1 levels
- Support non-invasive differential diagnosis
- Monitor disease activity and treatment efficacy
- Predict renal outcome and relapse risk
5. Product Empowerment by ANT BIO PTE. LTD.
ANT BIO PTE. LTD. offers the Mouse IgA Surpass ELISA PairSet Kit (Cat. No. S0H2015) under the Absin product line, a pre‑validated reagent set for high‑performance IgA quantification.
Core Product Advantages
|
Core Product Advantages |
|
Optimized Antibody Pairing: Carefully screened capture and biotinylated detection antibodies ensure high specificity, low background, and minimal cross-reactivity. |
|
High Sensitivity & Wide Range: Enables pg‑level sensitivity with a broad linear range for accurate quantification from low to high IgA concentrations. |
|
Flexible & Cost‑Effective: Provides core antibody reagents for custom assay development, supporting diverse sample types and high-throughput workflows. |
|
Stable & Reproducible: Strict quality control ensures consistent performance for long-term studies. |
Key Application Values
|
Key Application Values |
|
Mucosal & Gut Immunity: Quantify IgA in intestinal lavage, BALF, feces, and bile. |
|
B‑cell & Humoral Immunity: Evaluate IgA production after infection, vaccination, or stimulation. |
|
IgA Nephropathy Models: Monitor abnormal IgA levels in mouse renal disease studies. |
|
Vaccine & Adjuvant Research: Assess mucosal and systemic IgA immune responses. |
|
Monoclonal Antibody Development: Screen IgA‑secreting hybridoma clones. |
6. Brand Mission
ANT BIO PTE. LTD. is a trusted provider of life science reagents, supporting researchers worldwide with high‑performance antibodies, recombinant proteins, ELISA kits, and general laboratory reagents. We operate three specialized sub‑brands:
- Absin: General reagents, buffers, and assay kits
- Starter: High‑quality antibodies for research and diagnostics
- UA: Recombinant proteins for immunization, validation, and standardization
7. Related Product List
- Mouse IgA Surpass ELISA PairSet Kit (Absin, S0H2015)
- IgA monoclonal antibodies (Starter)
- Recombinant IgA proteins (UA)
- ELISA buffers, substrates, and secondary reagents (Absin)
- Other immunology ELISA kits (Absin)
Brand Promotion Copy
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
